Specific tumour targeting effect of [89Zr]Zr-Df-ATG-101 and [89Zr]Zr-Df-anti-PD-L1 is evident from the tumour-to-blood ratios (Fig. 4b and d). The gene discussed is CD274; the disease is neoplasm.